Janux Therapeutics, Inc.

NasdaqGM:JANX Stock Report

Market Cap: US$889.8m

Janux Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGM:JANX Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
11 May 26SellUS$28,878Maria DobekIndividual2,038US$14.17
02 Jan 26SellUS$25,799Andy MeyerIndividual1,879US$13.73
02 Jan 26SellUS$20,073Maria DobekIndividual1,462US$13.73
02 Jan 26SellUS$34,394Thomas DiraimondoIndividual2,505US$13.73
02 Jan 26SellUS$110,829David CampbellIndividual8,072US$13.73
02 Jan 26SellUS$37,263Zachariah McIverIndividual2,714US$13.73
02 Jan 26SellUS$32,966Charles WinterIndividual2,401US$13.73

Insider Trading Volume

Insider Buying: JANX insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of JANX?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders3,980,3625.99%
Hedge Funds6,619,7599.97%
VC/PE Firms11,189,69316.8%
Institutions44,636,45167.2%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 88.05% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
18.4%
RA Capital Management, L.P.
11,189,693US$163.3m0%2.08%
8.91%
BlackRock, Inc.
5,433,053US$79.3m33.2%no data
6.88%
Janus Henderson Group plc
4,196,409US$61.2m-21.6%0.02%
5.82%
Prosight Management, LP
3,550,000US$51.8m48.4%8.84%
5.03%
Point72 Asset Management, L.P.
3,069,759US$44.8m166%0.07%
4.92%
Klaus Dorner
2,999,990US$43.8m0%no data
4.16%
FMR LLC
2,535,683US$37.0m-27.8%no data
4.04%
State Street Global Advisors, Inc.
2,464,017US$36.0m-36.1%no data
2.97%
Vanguard Capital Management, LLC
1,811,365US$26.4m0%no data
2.93%
TCG Crossover Management, LLC
1,789,617US$26.1m0%0.68%
2.63%
Alyeska Investment Group, L.P.
1,601,089US$23.4m23.1%0.06%
2.62%
Wellington Management Group LLP
1,597,650US$23.3m-0.78%no data
2.12%
Vanguard Portfolio Management, LLC
1,290,256US$18.8m0%no data
1.95%
Deep Track Capital, LP
1,187,290US$17.3m1,230%0.3%
1.88%
Geode Capital Management, LLC
1,146,724US$16.7m2.98%no data
1.79%
Balyasny Asset Management L.P.
1,090,147US$15.9m23.1%0.03%
1.64%
Logos Global Management, L.P.
1,000,000US$14.6m0%0.76%
1.61%
OrbiMed Advisors LLC
983,600US$14.4m-49.7%0.23%
1.33%
Nantahala Capital Management, LLC
809,914US$11.8m0%0.7%
1.26%
Irenic Capital Management LP
765,804US$11.2m0%0.91%
1.21%
Woodline Partners LP
738,032US$10.8m-28.2%0.04%
1.11%
Bank of America Corporation
674,761US$9.8m17.5%no data
1.09%
Morgan Stanley
664,056US$9.7m10%no data
0.99%
Squarepoint OPS LLC
604,000US$8.8m54.5%0.02%
0.83%
The Goldman Sachs Group, Inc.
504,654US$7.4m-51%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/05/31 18:22
End of Day Share Price 2026/05/29 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Janux Therapeutics, Inc. is covered by 20 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Etzer DaroutBarclays
Alec StranahanBofA Global Research
Joshua SchimmerCantor Fitzgerald & Co.